Tag Archives: IMPROVE-IT

FDA Declares: Keep Taking Your Vytorin

It’s official. Vytorin (ezetimibe/simvastatin) still does what it’s supposed to do—significantly decrease LDL cholesterol. FDA, yesterday, released its assessment of the now-notorious ENHANCE trial—which tested whether Vytorin was better than simvastatin alone in reducing arterial plaque in a group of patients with severe genetic high cholesterol. It wasn’t, and publication of the study set off […]
Posted in Regulatory | Also tagged , , , , , | 1 Comment
  • Categories

  • Meta